Drug Trial Radar · NCT03049189
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
324
Actual
Start
Feb 2, 2017
Primary completion
Nov 27, 2024
Study completion Nov 2029
Sponsor
- Lead sponsor
- ITM Solucin GmbHIndustry
- Sponsor type
- Industry
- Collaborators
- ABX CRO; PSI CRO
- First posted
- Feb 9, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to evaluate efficacy and safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide compared to targeted molecular therapy with Everolimus in patients with inoperable, progressive, somatostatin receptor-positive (SSTR+), neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET).
Conditions
- Neuroendocrine Tumors
Interventions
177Lu-edotreotide PRRTDrug
PRRT using 177Lu-edotreotide will be performed 3-monthly. A maximum of four cycles will be administered.
EverolimusDrug
Everolimus will be administered as a standard dosis of 10 mg daily which may be reduced where required for acceptable tolerability.
Amino-Acid SolutionOther
The Amino-Acid Solution (AAS) to be used in this study will contain a mixture of 25 g lysine and 25 g arginine diluted in 2000 mL of electrolyte solution, infused over 4 - 6 h, starting 30 - 60 min before PRRT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS)Time frame: From date of randomization until the date of first documented progression or death, assessed up to 30 months,
Locations
52 sites in 14 countries. Site status is shown where the registry gives one.
Banner Health d.b.a. Banner MD Anderson Cancer Center
Gilbert, Arizona
Stanford University
Stanford, California
Moffitt Cancer Center & Research Institute
Tampa, Florida
Northwestern Memorial Hospital
Chicago, Illinois
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan
Excel Diagnostics & Nuclear Oncology Center
Houston, Texas
Royal North Shore Hospital
Saint Leonards, New South Wales, Australia
Olivia Newton-John Cancer & Wellness Centre, Austin Hospital
Heidelberg, Victoria, Australia
Peter MacCallum Cancer Centre
Melbourne, Victoria, Australia
Fiona Stanley Hospital
Murdoch, Western Australia, Australia
Allgemeines Krankenhaus Wien
Vienna, Austria
Institut Jules Bordet
Brussels, Belgium
Universitaire Ziekenhuizen Leuven
Leuven, Belgium
University Hospital Olomouc
Olomouc, Czechia
University Hospital Motol
Prague, Czechia
Hospices civils de Lyon
Bron, France
Centre Jean Perrin
Clermont-Ferrand, France
HP Hôpital Beaujon
Clichy, France
Institut de Recherche en Cancérologie de Montpellier (IRCM)
Montpellier, France
CHU de Nantes - Hôtel Dieu
Nantes, France
IUCT-Oncopole
Toulouse, France
Zentralklinik Bad Berka GmbH
Bad Berka, Germany
Charité - Universitätsmedizin Berlin
Berlin, Germany
Universitätsklinikum Bonn
Bonn, Germany
Universitätsklinikum Erlangen
Erlangen, Germany
Universitätsklinikum Essen
Essen, Germany
University Medical Center, Abteilung für Nuklearmedizin
Hamburg, Germany
Universitätsklinikum Magdeburg A.ö.R., Otto-von-Guericke Universität
Magdeburg, Germany
Philipps Universität Marburg
Marburg, Germany
Klinikum rechts der Isar Technische Universität München
Munich, Germany
Universitätsklinikum Ulm
Ulm, Germany
Universitätsklinikum Würzburg
Würzburg, Germany
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl
Meldola, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
European Institute of Oncology (EIO)
Milan, Italy
Academic Medical Center, University of Amsterdam
Amsterdam, Netherlands
MSC Memorial Cancer Centre
Gliwice, Poland
"Gammed" Izabela Chuchrowksa
Warsaw, Poland
University Cape Town (UCT), Groote Schuur Hospital
Cape Town, South Africa
University of Pretoria & Steve Biko Academic Hospital
Pretoria, South Africa
Showing 40 of 52 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.